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Abstract: Numerous hydrogels made of poly-γ-glutamic acid (γ-PGA) and various cross-linkers
have been explored, but only limited data on hydrogels made of γ-PGA and poly(ethylene glycol)
(PEG) are available. In this study, γ-PGA, a biodegradable and edible biopolyamide, was successfully
cross-linked with selected PEGs to obtain a series of hydrogels. The swelling behaviour of these
hydrogels was investigated under various pH conditions. It was also found that the structure of
the cross-linker (linear or branched) affected the hydrogels’ swelling behaviour. In addition, in disc
diffusion assay, hydrogel discs loaded with antibiotic were tested against Staphylococcus aureus and
Escherichia coli. Prolonged activity of hydrogels loaded with antibiotics in comparison to paper discs
containing antibiotics was observed. Moreover, the protective effect of hydrogels on entrapped
probiotic cells subjected to low pH was investigated. The hydrogel swelling ratio and amount
influenced the survival rate of the protected bacteria. Considering potential biomedical applications
of hydrogels, cytotoxicity was evaluated towards two cell lines, MSTO and PANC 1.
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1. Introduction
Hydrogels are three-dimensional polymer networks that are capable of retaining large amounts of
water or biological fluids, and simulating biological tissue [1,2]. Hydrogels have been obtained from
various polymers of natural origin, for example, polysaccharides, as well as from numerous synthetic
polymers, such as poly(ethylene glycol) [3]. On the basis of the cross-linking mechanism, hydrogels
can be classified into two categories, physical and chemical [1]. Physical cross-links have been formed
by ionic interaction, hydrogen bonding, or crystallite formation. In chemically cross-linked hydrogels,
covalent bonds have been present between polymer chains, e.g., as a result of reactions of functional
groups occurring along polymeric chains with bi- or multifunctional cross-linkers [4].
Hydrogels, due to their similarity to natural tissue, are suitable for various biomedical applications,
such as drug-delivery systems, scaffolds for tissue engineering, wound dressings, or contact lenses [5,6].
In addition, an important area of hydrogel application is personal-hygiene products such as nappies,
sanitary pads, or adult-incontinence products [7]. Moreover, due to their unique properties, hydrogels
could also find applications in many other fields, e.g., the food industry [8] or agriculture [9].
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Poly-γ-glutamic acid (γ-PGA), a biopolymer produced by bacteria, is made of D- and L-glutamic
acid units connected by amide linkages [10]. γ-PGA is produced on an industrial scale (mostly
from biomass by microbial fermentation), so it is relatively easily available. This naturally occurring
polyamide is water-soluble, biodegradable, nontoxic to humans and the environment, and safe
for human consumption [11]. Due to its edibility, γ-PGA has been tested for various food-related
applications, e.g., as a texture modifier for baked foods, bitterness-relieving agent, or cryoprotectant
for probiotic bacteria [12,13]. γ-PGA has also been used for medical applications, e.g., in tissue
engineering [14] or delivery systems [15]. In addition, γ-PGA could be used to prepare hydrogels with
properties suitable for pharmaceutical applications [16]. γ-PGA-based hydrogels are not limited to
only medical applications; they could also be used to purify turbid water [17] or as electrolytes in
organic electrochemical supercapacitors [18].
Poly(ethylene glycol) (PEG) is a water-soluble and nontoxic polymer, approved by the United
States Food and Drug Administration (FDA). PEG has been extensively used in a variety of medical
applications, such as drug-delivery systems or tissue engineering [19]. Moreover, PEG has been
used to obtain hydrogels suitable for biomedical applications, e.g., in delivery systems [20], tissue
engineering [21], or wound dressings [22].
Despite intensive research interest in poly-γ-glutamic acid, there are limited literature data on
hydrogels made of poly-γ-glutamic acid and poly(ethylene glycol). One of the few examples is hydrogels
obtained via photopolymerisation from methacrylated poly(γ-glutamic acid) and poly(ethylene glycol)
diacrylate; on the basis of a cytotoxicity assay of these pH-sensitive hydrogels, they were found suitable
for biomedical applications (as a matrix for pH-dependent drug release or scaffolding material in tissue
engineering) [23]. Another example of γ-PGA–PEG hydrogels was prepared in a reaction between
γ-PGA-containing maleimide groups and PEG-containing terminal thiol groups. This γ-PGA–PEG
hydrogel has the potential to be used as a drug-delivery system [24]. The synthesis of known
γ-PGA–PEG hydrogels was preceded by a modification of γ-PGA biopolymers in which additional
functional groups were introduced. The protocol reported in the current study allows to prepare
γ-PGA–PEG hydrogels in a one-step method under mild conditions. The hydrogels reported here
were synthesised via an esterification reaction between carboxyl groups naturally occurring in γ-PGA,
and hydroxyl groups of selected PEG cross-linkers.
The advantage of already known γ-PGA-based hydrogels has been proven in various fields,
including medical areas. Taking this into consideration, it seemed reasonable to conduct research
on developing γ-PGA-based hydrogels. In this study, a one-step method of obtaining γ-PGA-based
hydrogels in a reaction between a γ-PGA biopolymer and selected PEGs as cross-linkers was developed.
PEGs were chosen as cross-linkers due to their widespread use in the pharmaceutical and food
industries; hence, the human organism has frequent contact with these materials. Well-defined
PEGs with desired molecular weights are easily available and relatively cheap. The influence of
molecular weight and structure (linear or branched) of the cross-linker on swelling behaviour has been
investigated. Moreover, possibilities of using these hydrogels as drug- and probiotic-delivery vehicles
were examined. Studies on the cytocompatibility and antimicrobial activity of hydrogels loaded with
antibiotics on Gram-positive and -negative bacteria were undertaken. We investigated the protective
effect of γ-PGA-based hydrogels on entrapped probiotic cells subjected to low pH. The possibilities
of using γ-PGA–PEG hydrogels as probiotic-delivery vehicles had not been investigated until now.
Conducting research on γ-PGA–PEG hydrogels in the direction of oral-delivery vehicles seemed
reasonable, as both polymers have already been used as food additives.
2. Materials and Methods
2.1. Materials
Poly-γ-glutamic acid (Mw = 200,000–500,000 g/mol) was purchased from Wako Chemicals
Europe GmbH (Neuss, Germany). Poly(ethylene glycol) PEG1000 (Mw = 1000 g/mol) and glycerol
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ethoxylate PEG1000-3-arm (Mn = 1000 g/mol) were purchased from Sigma-Aldrich Chemie GmbH
(Steinheim, Germany). Poly(ethylene glycol) PEG400 (Mw = 400 g/mol), poly(ethylene glycol)
PEG200 (Mw = 200 g/mol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC),
4-dimethylaminopyridine (DMAP), and phthalate buffer solution (pH = 3.0) were purchased from Acros
Organics (Geel, Belgium). DMSO, acetone, phosphate buffered saline (PBS, pH = 7.4) were purchased
from Avantor Performance Materials Poland S.A. (Gliwice, Poland). Dialysis membrane Spectra/Por
(MWCO 6000–8000) was purchased from Carl Roth (Karlsruhe, Germany). Chloramphenicol powder
was purchased from Fisher Scientific UK (Loughborough, UK). Chloramphenicol discs were purchased
from Thermo Scientific (Hampshire, UK). Tryptic soy agar (TSA) was purchased from Lab M Ltd.
(Heywood, UK). Dulbecco’s Modified Eagle Medium (DMEM) was purchased from Gibco (UK); foetal
bovine serum (FBS), L-glutamine, and antibiotic antimycotic (10,000 units/mL penicillin, 10,000 µg/mL
streptomycin, and 25 µg/mL amphotericin B) were purchased from Gibco (UK). Thiazolyl blue
tetrazolium bromide (MTT) was purchased from Sigma-Aldrich (UK). NaCl (5.8 g/L) and glycine
(7.6 g/L), used for preparing Sorensen’s glycine buffer, were purchased from Sigma-Aldrich (UK).
MSTO-211H (human mesothelioma, CRL-2081) and PANC 1 (human pancreatic ductal adenocarcinoma,
CRL-1469) were purchased from ATCC (UK). Staphylococcus aureus NCIMB 6571 and Escherichia coli
NCIMB 9481 were obtained from the University of Wolverhampton culture collection. A mixture of
Lactobacillus strains (L. acidophilus, L. casei, and L. rhamnosus) was obtained from Holland and Barrett,
Ltd. (Nuneaton, UK).
2.2. Hydrogel Synthesis
γ-PGA (0.25 g) and DMSO (20 ml) were placed inside a round bottom flask equipped with a
magnetic stirring bar. After γ-PGA was dissolved, the remaining reagents were added (mol % toward
glutamic acid residue of γ-PGA): PEG (30 mol %), EDC (30 mol %), and DMAP (10 mol %) (quantities in
Table 1). The reaction mixture was stirred at room temperature. After 6 h, the mixture was precipitated
in acetone and centrifuged for 5 min at 7000 rpm. During centrifugation, hydrogel samples were
formed into discs. For purification, hydrogel samples were put into dialysis membranes and kept in
distilled water overnight. The resultant swollen hydrogels were lyophilised.
Table 1. Reagent quantities calculated per 0.25 g of poly-γ-glutamic acid (γ-PGA). Note: DMAP,
4-dimethylaminopyridine; EDC, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; PEG,
poly(ethylene glycol).
Cross-Linker





2.3. Nuclear-Magnetic-Resonance (NMR) Characterisation
NMR analyses were performed at room temperature using NMR Varian 300 MHz (Palo Alto, CA,
USA). Each spectrum was recorded with 32 scans, 1.71 s acquisition time, and 10 s relaxation delay.
Before analyses, samples were hydrolysed in a D2O solution of NaOH. Samples of dry hydrogels
(10 mg) were put into tubes containing 2.0 mL of D2O solution of NaOH (pH 10.0). The content of the
tubes was mixed at 60 ◦C for 24 h. Trimethylsilylpropanoic acid (TSP) was used as the internal standard.
The content of cross-linker X (mol %) of each hydrogel was calculated on the basis of 1H NMR spectra
from Equation (1).
X = [(Ad/4n*Ac)]*100, (1)
where Ad is the peak area of cross-linker protons (signal d in Figure 1), n is the number of repeating
units in PEG cross-linker, and Ac is the peak area of the γ-proton of PGA (signal c in Figure 1).
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2.4. SEM Analysis
Hydrogel morphology was evaluated using a Phenom ProX scanning electron microscope (SEM)
using accelerating voltage of 5 kV. Prior to the scanning process, lyophilised samples were sprayed
with a 10 nm gold layer using sputter Quorum Q150R ES.
2.5. Swelling Studies
The dried samples (with mass of 5–9 mg each) of the obtained hydrogels were put into 2.5 mL of
deionised water, phthalate buffer, and phosphate-buffered saline, and kept for 24 h at room temperature.
After incubation in the solutions, swollen samples were placed on a mesh sheet (Flow-Mesh™) to
remove excess of water and weighed. Then samples were lyophilised and weighted. Swelling
experiments were carried out in triplicate. Swelling ratio (SR; g/g) was calculated according to the
following formula.
SR = (Ws −Wd)/Wd, (2)
where Ws is the weight of the swollen hydrogel (g), and Wd is the weight of the dry hydrogel (g).
2.6. Studies on Antimicrobial Activity of Hydrogel Loaded with Antibiotics
The antimicrobial activity of hydrogels loaded with antibiotics was tested in a disc-diffusion assay.
A slightly soaked sheet of pure hydrogel was cut into discs with a diameter of 8 mm. Antibiotics were
introduced into the discs, and we applied to the centre of each hydrogel disc 200 µL of suspension of
chloramphenicol (30 µg) dropwise in Ringer’s solution with a pipette, and it was left to be absorbed.
Paper discs containing chloramphenicol (30 µg in each) and pure hydrogel discs were used as controls.
The antimicrobial activity of hydrogel discs containing antibiotics was tested against Staphylococcus
aureus and Escherichia coli. Overnig t cultures of both pathogens were seed d on the surface of TSA
plates. Hydrogel discs containing chloramphenicol, pa er disc with chloramphenicol, and pure
hydrogel discs wer aseptically placed on the TSA plates and incubated at 37 ◦C for 24 h. T en,
the diameter of th zones of inhibitio was measured, and the iscs of the sel ct d hydrogels were
transferred onto freshly seeded TSA plates and further incubated at 37 ◦C. The diameter of the zones
of inhibition was measured again after 24 and 96 h. The tests of antimicrobial activity of each hydrogel
were carried out in triplicate.
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2.7. Probiotic Survival in Acid Environments
The protective effect of the selected γ-PGA-based hydrogels was investigated using mixture
of three probiotic strains, L. acidophilus, L. casei, and L. rhamnosus, under pH = 1.5 and pH = 3.0.
The hydrogel samples (25 or 50 mg each) absorbed 0.5 mL of the suspension of Lactobacillus in Ringer’s
solution. Hydrogels with probiotic bacteria, as well as 0.5 mL of suspension of free cells in Ringer’s
solution, were subjected to an acidic solution and incubated at 37 ◦C. Triplicate samples were withdrawn
after 2 and 4 h. Hydrogel samples in Ringer’s solution were shaken on a vortex mixer to release the
bacteria. A serial dilution of bacteria suspension was prepared up to 10−6; then, 20 µL of each cell
suspension was aseptically plated out in duplicate on the TSA plates. Plates were incubated at 37 ◦C,
and cell viability was determined by counting the CFU/mL.
2.8. Cytotoxicity Assays
In vitro cytotoxicity was evaluated after direct contact of the samples of hydrolysed hydrogel
with MSTO-211H (human mesothelioma, CRL-2081 from ATCC, UK) and PANC 1 (human pancreatic
ductal adenocarcinoma, CRL-1469 from ATCC, UK) cell lines at a ratio of 5 mg of hydrolysate/mL of
medium. Before the cytotoxicity assays, two more purification cycles of the hydrogel samples were
performed. During one cycle, samples were kept in distilled water overnight and lyophilised. In order
to obtain the hydrolysate, hydrogel samples were incubated for 72 h at 37 ◦C in Dulbecco’s Modified
Eagle’s Medium (DMEM) medium. Cell lines were cultured in DMEM containing 4.5 g/L glucose,
supplemented with foetal bovine serum (FBS), antibiotic antimycotic, and L-glutamine at 37 ◦C in a
humidity incubator with 5% CO2. Briefly, 5000 cells were seeded per well (96-well plate) for 24 h at
37 ◦C in a 5% CO2 incubator. The cells were then exposed to the hydrolysate of the hydrogel sample
in DMEM for 24 h to investigate the effect on cell viability. Cells in DMEM were used as a control.
Cell viability was evaluated following the standard MTT assay, as previously reported [6].
2.9. Statistical Analysis
Experiments were performed in at least triplicate, and data are expressed as mean ± standard
deviation; p < 0.05 was considered to be statistically significant. Data recorded in MTT assays were
analysed statistically by two-way analysis of variance (ANOVA) with Tukey’s multi comparison test
using GraphPad Prism.
3. Results
γ-PGA-based hydrogels were obtained via an esterification reaction between carboxyl groups
present along the γ-PGA chain and hydroxyl groups of the selected PEG cross-linkers (Scheme 1).
The aim of the study was to establish the influence of cross-linker chain length on the swelling
properties of the obtained hydrogels. Poly(ethylene glycol)s with various chain lengths are easily
available and relatively cheap diols, so three linear PEGs, PEG200, PEG400 and PEG1000, were selected
as cross-linkers in this study. Moreover, the influence of the cross-linker structure on swelling behaviour
was investigated by comparing the swelling ratio of the obtained hydrogel using a linear PEG1000
cross-linker with the swelling ratio of the hydrogel with a branched PEG1000 cross-linker (3-arm with
total Mn = 1000 g/mol).
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Scheme 1. Synthesis of γ-PGA-based hydrogels using PEGs as cross-linkers.
3.1. Composition of γ-PGA–PEG Hydrogels
To determine hydrogel composition, the samples were hydrolysed, and obtained mixtures were
analysed using 1H NMR. Samples of dried hydrogels were subjected to a D2O solution of NaOH.
At the beginning of each experiment, samples significantly swelled and dissolved completely after
several hou s. The observed dissolution of th sample was the xpected ffect accompanying the
progress f the hydrolysis process, in which ester bonds between t e cross-linker and γ-PGA break
down. The 1H NMR spectrum of the sample obtained as a result of the hydrolysis of γ-PGA–PEG1000
hydrogel is presented in Figure 1A. In this spectrum, signals corresponding to the protons of the
γ-PGA chain (signals a-c), as well as signal corresponding to protons of the PEG cross-linker (signal d),
are visible. The cross-linker content of each hydr gel was calculated from 1H NMR spectra on the
basis of signals corresponding to c oss-linker protons (signal d in Figu e 1) and the γ-proton of PGA
(signal c in Figure 1). It was established that the cross-linker content was quite similar in all hydrogels
(between 10 and 13 mol %). Moreover, it was found that the obtained hydrogels were purified by
the byproducts (e.g., isourea byproduct of EDC) or the remaining reagents used in the synthesis.
The signals c responding to protons f DMAP (Figure 1B) and EDC (Figure 1C) were not visible in
the spectrum of the hydrolysed hydrogel (Figure 1A).
3.2. Morphology of γ-PGA–PEG Hydrogels
Figure 2 shows the SEM images of the selected γ-PGA-based hydrogels obtained from an
esterification reaction between γ-PGA and the selected cross-linkers: PEG200, PEG400, PEG1000 and
PEG1000-3arm. For each sample, a porous hydrogel structure with evenly distributed pores was
detected. The structure with the biggest pores was visible in the sample of the hydrogel obtained using
PEG1000 (Figure 2e,f), the cross-linker with the longest chains among those tested. In the hydrogel
obtained using a branched cross-linker with a similar molecular weight, PEG1000-3arm, the smallest
pores were observed (Figure 2g,h).
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3.3. Hydrogel Swelling Behaviour
Studies on the swelling behaviour of the obtained hydrogels were carried out under various
conditions: in deionised water, and in aqueous solutions at pH = 3.0 (phthalate buffer) and pH = 7.4
(phosphate-buffered saline). Samples of the swollen hydrogels, as well as the ones dried in a desiccator,
were transparent. For each tested hydrogel, the SR was the highest after soaking in deionised water
(see Figure 3). The swelling ratio for each hydrogel soaked in phthalate buffer and in phosphate-buffered
saline was significantly lower than the SR achieved in deionised water.
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Figure 3. Studies on swelling behaviour of γ-PGA-based hydrogels carried in phthalate buffer at
pH = 3.0, deionised water, and phosphate-buffered saline at pH = 7.4 (n = 3; error bars, standard
deviation; ns = nonsignificant with p > 0.05).
As seen in Figure 3, the highest swelling ratio among all tested hydrogels and conditions, reaching
almost 350 g/g (345.7 ± 5.4 g/g), was observed for hydrogels with the PEG1000 cross-linker after soaking
in deionised water. The SR of the hydrogel with PEG1000 after incubation in deionised water was more
than twice as high as the SR of the hydrogel with PEG400, while using 3-arm PEG1000 cross-linker
resulted in hydrogel with the lowest SR under those conditions. For the tested hydrogels, swelling
ratio increased with the increase of the molecular weight of the linear cross-linkers. However, for
hydrogels containing cross-linkers with the same molecular weight, linear PEG1000 and branched
PEG1000, the cross-linker structure seemed to be the determining factor on the swelling behaviour of
the hydrogels. A similar influence of cross-linker chain length and structure n hydrogel swelling
behaviour was observed under each ested conditi n. Those results could be linked with the porous
structure of the hydroge s observed in SEM images. A ydrog l-cont ining cross-linker with the longest
chains, PEG1000, had the highest SR among the tested hydrogels. As can be seen on SEM images, the
γ-PGA–PEG1000 hydrogel had a meshlike structure with the biggest pores. Such a structure provided
more space for water than a cross-linker with shorter chains does.
To establish changes in swelling behaviour over soaking time, the SR values of the γ-PGA-based
hydrogels soaked in deionised water were measured at different time intervals. The experiment was
carried out for 240 min. As seen in Figure 4, in the first part of the experiment, the swelling ratio
increased with increasing length of soaking time. Then, between 120 and 150 min, the SR achieved
almost constant values, which were similar with the SR values after soaking for 24 h (see Figure 3).
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3.4. Antim crobial Activ ty of γ-PGA–PEG ydro ith Antibiotics
Studies on the antimicrobial activity of hy rogels loa ed with chloramphenicol were carried out
against S. aureus and E. coli. After 24 h, pure hydrogel discs exhibited no antimicrobial activity toward
the tested pathogens, while paper discs with antibiotics gave larger zones of inhibition than hydrogel
discs loaded with antibiotics did (see Table 2).
Table 2. Inhibitory effect of hydrogel discs loaded with antibiotics toward S. aureus and E. coli (n = 3).
Diameter of Zone of Inhibition (mm)
Sample
S. aureus E. coli
i tics Hydrogel + Antibiotics Ant biotics Hydrogel + Antibiotics
PEG200 22.6 ± 2.5 16.3 ± 2.9 17.3 ± 1.5 9.7 ± 2.9
PEG400 .1 ± . 19.3 ± 0.6 18.3 ± 0.6 15.3 ± 0.6
PEG100 -3arm .6 ± . 19.0 ± 1.0 18.6 ± 0.6 14.7 ± 1.5
For the PEG1000-3arm hydrogel, the experiment was continued after the first 24 h, and the tested
samples (pure hydrogel, hydrogel loaded with antibiotics, and paper disc) were transferred onto
freshly seeded TSA plates. The paper discs with antibiotics showed inhibition zones that were only
slightly larger than the diameter of those discs (Table 3). During the last measurement, hydrogel discs
loaded with antibiotics exhibited zones of inhibition that were almost similar to the ones measured
after 24 h. During the test, hydrogel discs absorbed water from the surroundings, and their volume
visibly i creased. Between 48 and 120 h, the hy rogel discs wer dissolved, so the entire rem ining
amount f antibiotics could b rel as . In addition, small zones of inhibition wi h irregular and
har -to-measure shapes were observed f r pure ydrogel discs after 120 h, while, after 48 h, these
discs exhibited no antimicrobial activity towards the tested pathogens.
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Table 3. Inhibitory effect of PEG1000-3arm hydrogel discs loaded with antibiotics toward S. aureus and
E. coli (n = 3).
Diameter of Zone of Inhibition (mm)
Total Time (h)
S. aureus E. coli
Antibiotics Hydrogel + Antibiotics Antibiotics Hydrogel + Antibiotics
24 23.6 ± 1.2 19.0 ± 1.0 18.6 ± 0.6 14.7 ± 1.5
48 a 5.0 ± 0.1 13.0 ± 1.0 5.0 ± 0.1 -
120 b 5.0 ± 0.1 18 ± 1.7 5.0 ± 0.1 13.7 ± 0.6
After first 24 h, samples were transferred onto freshly seeded tryptic soy agar (TSA) plates, and zones of inhibition
were measured again after another 24 h a and 96 h b.
3.5. Protective Effect of γ-PGA-Based Hydrogels on Probiotic Cells in Low pH
The results of the protective effect of the selected γ-PGA-based hydrogels on probiotic bacteria in
pH 3.0 and 1.5, expressed as Log10 CFU/mL, are presented in Figures 5 and 6. For the test carried out
in pH 3.0, 25 mg hydrogel samples were used, while the test carried out in pH 1.5 was performed for
25 and 50 mg of the hydrogel samples. For free cells and cells entrapped in the PEG400 and PEG1000
hydrogels, similar loss in cell viability was observed (2.62, 2.58, and 2.66 Log CFU/mL, respectively)
after incubation for 2 h at pH 3.0 (Figure 5). At the same time, loss in cell viability for bacteria entrapped
in the PEG1000-3arm hydrogel was significantly lower (0.89 Log CFU/mL). After 4 h of the experiment,
the viable cell count of the free cells and cells entrapped in the PEG400 and PEG1000 hydrogels
further decreased (reaching values of 2.80, 3.84, and 2.86 Log CFU/mL, respectively), although for cells
entrapped in the PEG400 hydrogel, the decrease was smaller than that after the first experiment period.
Cells entrapped in the PEG1000-3arm hydrogel maintained the highest viability (5.54 Log CFU/mL).
Importantly, the survival rate of probiotic bacteria in the PEG400 and PEG1000-3arm hydrogels after
exposure to acid conditions for 4 h was higher than that for free cells.
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Total loss in viability of free cells was observed after incubation at pH = 1.5 for 2 h, while bacteria
entrapped in the hydrogels survived for 4 h under these conditions (Figure 6). After 2 and 4 h, loss
in cell viability for bacteria entrapped in 25 mg of the PEG1000-3arm hydrogel was lower than that
for bacteria entrapped in 25 mg of the PEG400 hydrogel. Similar results were observed for the test
performed at pH = 3.0. Increasing the hydrogel amount to 50 mg per sample visibly improved the
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cell survival rate, e.g., bacteria entrapped in 50 mg of the PEG1000-3arm hydrogel maintained a cell
population of 6.53 Log CFU/mL after incubation for 2 h in pH = 1.5. The viable cell count of cells
entrapped in 50 mg of both hydrogels after 4 h of incubation in a solution with pH = 1.5 was higher
than 4.0 Log CFU/mL.Appl. Sci. 2020, 10, x FOR PEER REVIEW 10 of 15 
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3.6. Preliminary Cytotoxicity Assay
The cytotoxicity of the hydrolysed γ-PGA–PEG400 hydrogel was evaluated towards the MSTO
and PANC 1 cell lines. Cell viability was determined after 24 h of culture by MTT assay. The MSTO
cell line aintained viability of 79% ± 13%, and the PANC 1 cell line with 67% ± 16% cell viability
(p = 0.0621; Figur 7). Both the t sted human cell lines demonstrated good survival rate, confirming
the cytocompatible nature of the γ-PGA–PEG400 hydrogel.
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4. Discussion
γ-PGA–PEG hydrogels were obtained from an esterification reaction between γ-PGA biopolymers
and linear PEG cross-linkers with different chain lengths, as well as with a branched PEG cross-linker.
The swelling behaviour of the obtained hydrogels was investigated in deionised water, in phthalate
buffer at pH = 3.0, and in phosphate-buffered saline at pH = 7.4. The highest swelling ratio was
achieved after soaking the hydrogel samples in deionised water. While the SR of each hydrogel soaked
in phthalate buffer and in phosphate-buffered saline was significantly lower than the SR achieved after
soaking in deionised water, the achieved SR values at both buffers were quite similar. Differences
in swelling in deionised water and in the buffers might be associated with the influence of ionic
concentration. According to the literature, the swelling behaviour of γ-PGA hydrogels is associated
with repulsive forces between -COO− groups. The absence of cations in deionised water allows
strong electrostatic repulsion between -COO− groups, which enables high swelling values. In buffers,
the number of additional cations caused weakened electrostatic repulsion between –COO− due to
the chelation between –COO− groups and cations, which presumably lead to a depressed swelling
degree [25].
On the basis of the conducted research, we found that the swelling ratio of hydrogels increased
with the increase of the cross-linker’s chain length. Such a tendency was observed for each tested
condition (deionised water, pH = 3.0, and pH = 7.4). Different cross-linker amounts in each hydrogel
might have affected the swelling behaviour. Increasing cross-linker concentration could result in
a network with more cross-linking points (higher cross-linking density); therefore, there would be
less space for water [26]. However, on the basis of conducted 1H NMR analysis of the hydrolysed
hydrogels, the cross-linker amount was similar in all hydrogels. Therefore, it could be assumed
that the swelling behaviour of the obtained hydrogels mainly depended on cross-linker chain length.
Cross-linker chain length influences swelling behaviour; using a cross-linker with longer chains results
in an increase of the hydrogel swelling ratio in comparison to a hydrogel with shorter cross-linker
chains [27,28]. Moreover, it was found that the use of a branched cross-linker resulted in obtaining
a hydrogel with a lower swelling ratio in comparison to the application of a linear cross-linker with
similar molecular weight. The more water that a hydrogel was able to absorb (the higher SR), the
larger the pores that were generated during lyophilisation. Thus, in the SEM image of PEG1000, the
biggest pores are visible (Figure 2e,f), in the SEM image of the PEG1000-3arm, the smallest pores can
be observed (Figure 2g,h), and a rather similar size of pores was observed in PEG200 (Figure 2a,b)
and PEG400 (Figure 2c,d). On the basis of the obtained results, we established the influence of the
molecular weight of the PEG cross-linker, as well as the cross-linker structure (linear or branched),
on the swelling ratio of the γ-PGA-based hydrogels. In the current study, the lowest SR = 6.0 ± 0.4 g/g
was achieved after soaking the γ-PGA-based hydrogel with 3-arm PEG1000 cross-linker in phthalate
buffer at pH = 3.0. The materials that achieved a low swelling ratio under acidic conditions may be
useful for intestine-delivery vehicles. This is because such vehicles are first subjected to highly acidic
conditions in the stomach, where contact between the contents of those delivery vehicles and the
harmful medium should be limited. Then, the release of the active substance from intestine-delivery
vehicles should occur after subjecting them to gradually increasing pH, from pH = 5.5 in the small
intestine to about pH = 7.5 in the ileocolonic region [29].
In order to investigate the possibility of using synthesisedγ-PGA-based hydrogels as drug-delivery
vehicles, studies on the antimicrobial activity of hydrogels loaded with antibiotics were carried out.
During a disc-diffusion assay, pure hydrogel discs, hydrogel discs loaded with antibiotics, and a paper
disc containing antibiotics were tested against selected pathogens. S. aureus and E. coli were chosen
to represent Gram-positive and -negative bacteria. Both pathogens are the most common cause of
healthcare-associated infections [30]. Chloramphenicol, an antibacterial agent with a broad spectrum
of activity against Gram-positive and -negative bacteria [31], was used as a model drug. Paper discs
containing antibiotics and hydrogel discs loaded with antibiotics exhibited antimicrobial activity
against E. coli and S. aureus. After 24 h of the experiment, higher antimicrobial activity against both
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pathogens was observed for antibiotics released from the paper discs. It could be assumed that, during
the first period of the experiment, only a small amount of antibiotics was released from the hydrogel
discs, and that dose was too low to indicate a similar effect as the antibiotics release from the paper
discs. However, after transferring hydrogel discs loaded with antibiotics and paper discs onto freshly
seed TSA plates, the hydrogel discs with antibiotics showed noticeably higher antimicrobial activity
against the tested pathogens. Along with extending the duration of the experiment, more drugs were
released from the hydrogel discs, resulting in observed antibacterial activity up to 120 h. The performed
experiment indicated prolonged activity of hydrogels loaded with antibiotics in comparison to paper
discs containing antibiotics. Moreover, hydrogel discs dissolved during the experiment, which might
be the result of the hydrolysis of ester bonds caused by humidity and/or enzymes produced by bacteria.
Such hydrogel behaviour may be desirable for certain applications, such as wound dressing [32].
The antibacterial effect of pure hydrogel discs observed after 120 h could be explained just by the low
pH generated by the hydrolysis of the hydrogel.
The developed γ-PGA–PEG hydrogels were tested as probiotic-delivery systems. The protective
effect of γ-PGA-based hydrogels on probiotic cells in low pH was determined. Various hydrogels are
known as materials that might improve the survivability of probiotic bacteria under gastrointestinal-
track conditions, as well as during storage at various temperatures [33]. Moreover, the γ-PGA
biopolymer was already successfully tested as a delivery vehicle for probiotic bacteria [12,34].
Those facts encourage further research, during which the suitability of γ-PGA-based hydrogels
for applications as probiotic-delivery systems could be investigated. In the human stomach, probiotic
bacteria are subjected to gastric acidic with low pH. Immediately after consuming certain food and
drinks, gastric pH could be elevated to a value in the range of 3.0–4.0; however, this decreases over
time to a value below 2.0 [29]. Therefore, the protective effect of the selected γ-PGA-based hydrogels
on probiotic bacteria was tested under various pH values, 3.0 and 1.5, respectively. The viability of the
tested probiotic bacteria entrapped in the hydrogels was mostly higher than that of free cells subjected
to pH 3.0 and pH 1.5. Certain differences in the viability of bacteria protected by PEG400, PEG1000, and
PEG1000-3arm were observed. Those differences might be related to the different swelling behaviours
of those hydrogels; the PEG1000-3arm hydrogel had a lower SR under acidic conditions than that of
the PEG400 and PEG1000 hydrogels. Less of the harmful medium could penetrate inside a less swollen
PEG1000-3arm hydrogel; thus, contact between entrapped probiotic bacteria and acid medium is more
limited. This is in contrast to the hydrogel with the linear PEG1000 cross-linker, which had the highest
swelling ratio between the tested hydrogels. Presumably, the high SR value is the reason why the
viability rate of the bacteria entrapped in this hydrogel was similar to the viability of the free cells.
The main differences in the survival level of probiotic bacteria was visible after incubation in pH 1.5;
under these conditions, free cells were not able to survive for 2 h, while protected cells could maintain
a certain level of viability after 4 h. Moreover, it was found that increasing the hydrogel amount may
further improve bacterial survival under acidic conditions. A larger gel amount might provide a
thicker barrier between probiotic bacteria and harmful environments, especially for bacteria in the core
of hydrogel samples. The obtained results proved the bacterial protective ability of the synthesised
γ-PGA-based hydrogels in a solution with low pH. It was established that the hydrogel swelling ratio
and amount had noticeable influence on the survival rate of bacteria protected by hydrogels.
Products that claim to contribute to the improvement of intestinal microflora should contain
a minimum 106 CFU/mL of probiotic bacteria [35]. Depending on the consumed food and drinks,
gastric-residence time could vary between 15 and 194 min [29]. Probiotic bacteria entrapped in 50 mg
of the γ-PGA–PEG1000-3arm hydrogel maintained a cell population of 6.53 ± 0.31 Log CFU/mL after
incubation for 2 h in pH = 1.5. Despite visible loss in cell viability for bacteria protected by the
hydrogels after 4 h of incubation in pH 1.5, the γ-PGA-based hydrogels could be further investigated
to develop probiotic-delivery systems. Synthesised hydrogels demonstrated improved viability of the
entrapped probiotic bacteria under acidic conditions in comparison to free cells. If a sufficiently high
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starting dose of bacteria were introduced into the appropriate γ-PGA-based hydrogel amount, and
subjected to low pH, such a delivery system could contain the required amount of viable bacteria.
In order to evaluate in vitro cytotoxicity, two cell lines, MSTO and PANC 1, were treated with
hydrolysed γ-PGA–PEG400 hydrogel. On the basis of the obtained results, it was observed that the
presence of hydrolysis products negatively affected the cellular viability of both tested lines. However,
percentages of cell viability in the range of 80%–60% were still recognised as weak cytotoxicity [36].
5. Conclusions
The γ-PGA-based hydrogels were synthesised using PEGs with different chain lengths as
cross-linkers. It was established that the swelling ratio of obtained hydrogels increased with the
increasing chain length of cross-linkers. Different swelling behaviour may be required for different
applications, so determining the relationship between cross-linker features and swelling ratio is vital
for designing hydrogels for selected applications. On the basis of the results, we found that the swelling
ratio of γ-PGA–PEG hydrogels could be controlled by applying a PEG cross-linker with appropriate
chain length and/or structure. Taking into consideration the availability of PEGs with different chain
lengths, as well as with different structures, it can be presumed that there is a broad range of possibilities
to obtain γ-PGA–PEG hydrogels with swelling properties tailored for specific applications.
In addition, results of the current research demonstrated the antimicrobial activity of hydrogels
loaded with antibiotics against the tested pathogens. Moreover, it was established that the obtained
hydrogels improved the viability of entrapped probiotic bacteria under acidic conditions, and
are cytocompatible.
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